(Q40836526)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

review article

1 reference

title

Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Report of the DNA Cytometry Consensus Conference (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

author name string

Clark GM

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Cornelisse CJ

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Killander D

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Kute T

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

Merkel D

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

number of pages

4

1 reference

inferred from page(s)

published in

Cytometry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

30 October 2019

page(s)

482-485

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8354119%20AND%20SRC:MED&resulttype=core&format=json

DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

30 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

DNA ploidy of primary breast cancer and local recurrence after breast-conserving therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

DNA index, S-phase fraction, histological grade and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

Nuclear DNA content as a prognostic factor in T1-2N0 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Prognostic significance of DNA-ploidy in a series of 690 primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

DNA ploidy and survival in breast cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Prognostic significance of the DNA content of human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

DNA flow cytometry, nuclear morphometry, mitotic indices and steroid receptors as independent prognostic factors in female breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Prognostic significance of DNA measurements in 409 consecutive breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. A retrospective study of 227 consecutive cases

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

One or multiple samplings for flow cytometric DNA analyses in breast cancer-prognostic implications?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

DNA flow cytometric analysis of primary operable breast cancer. Relation of ploidy and S-phase fraction to outcome of patients in NSABP B-04.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

DNA ploidy and other results of DNA flow cytometry as prognostic factors in operable breast cancer: 10 year results of a randomised study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomas.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Improved prognostic impact of S-phase values from paraffin-embedded breast and prostate carcinomas after correcting for nuclear slicing.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Aneuploid DNA content and high S-phase fraction of tumour cells are related to poor prognosis in patients with primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

How reproducible are flow cytometry data from paraffin-embedded blocks?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

The relation of flow cytometry to clinical and biologic characteristics in women with node negative primary breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Lymph node metastases versus DNA ploidy as prognostic factors for invasive ductal carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Proliferative activity, histological grade and benefit from adjuvant chemotherapy in node positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

The prognostic significance of ploidy analysis in operable breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

Indicators of prognosis in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

The Multivariate Prognostic Index and nuclear DNA content are independent prognostic factors in primary breast cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

The importance of DNA flow cytometry in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021

DNA content flow cytometry as a prognostic factor for node-positive breast cancer. The role of multiparameter ploidy analysis and specimen sonication

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.990140505

7 January 2021